DEBBANE RAYMOND purchased 19.4% of their position (268.50K shares) of LEXICON PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $352.9K — a significant purchase. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 2/18/2026ACC: 0001062822-26-000029
Director
Since Feb 2026
+268.50K
Net shares
Net buyer
$352.9K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
268.50K acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+57.95K
Price / share
$1.31
Trade value
$75.88K
% of position
4.2%
2/13/2026
1.39M→1.44M
Common Stock
Direct
Shares
+76.86K
Price / share
$1.31
Trade value
$100.54K
% of position
5.3%
2/17/2026
1.44M→1.52M
Common Stock
Direct
Shares
+133.69K
Price / share
$1.32
Trade value
$176.47K
% of position
8.8%
2/18/2026
1.52M→1.65M
Total
Net shares
+268.50K
Net value
$352.89K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/13/2026 | P · Purchase | +57.95K | $1.31 | $75.88K | 4.2% | 1.39M | 1.44M |
| Common Stock Direct | 2/17/2026 | P · Purchase | +76.86K | $1.31 | $100.54K | 5.3% | 1.44M | 1.52M |
| Common Stock Direct | 2/18/2026 | P · Purchase | +133.69K | $1.32 | $176.47K | 8.8% | 1.52M | 1.65M |
| Total | +268.50K | $352.89K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned7.36M
Common Stock
IndirectShares owned1.54M
Common Stock
IndirectShares owned35.40M
Common Stock
IndirectShares owned5.45M
Total
49.75M indirect49.75M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 7.36M | Indirect |
| Common Stock | 1.54M | Indirect |
| Common Stock | 35.40M | Indirect |
| Common Stock | 5.45M | Indirect |
| Total | 49.75M | 49.75M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported